Matthew Strobeck

BDSX

Matthew Strobeck serves as director at Biodesix, Inc. (BDSX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

5 trades

$4.63M

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$4.63M

Companies Traded

QDEL, BDSX

Active Period

Dec 2021 – Feb 2026

5 total trades

Most Recent

Buy QDEL

Feb 13, 2026 · $239.6K

Matthew Strobeck's Insider Trading at Biodesix, Inc. (BDSX)

Buys

4 · $4.39M

Sells

0 · $0.00

Total Shares Bought

3,089,936

Total Shares Sold

BDSX Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value
Nov 5, 2024	Buy	40,000	$1.40	$55.9K
Nov 21, 2022	Buy	2,343,477	$1.15	$2.69M
Apr 7, 2022	Buy	558,659	$1.79	$1.00M
Dec 30, 2021	Buy	147,800	$4.35	$642.9K

Matthew Strobeck's Insider Trading at QuidelOrtho Corporation (QDEL)

Buys

1 · $239.6K

Sells

0 · $0.00

Total Shares Bought

10,000

Total Shares Sold

QDEL Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Feb 13, 2026	Buy	10,000	$23.96	$239.6K	27,775

Related Insiders

Chris Vazquez

officer: Chief Accounting Officer

BDSXSell · Feb 23, 2026

Robin Harper Cowie

officer: CFO, Sec'y & Treasurer

BDSXSell · Feb 23, 2026

Scott Hutton

President & CEO

BDSXSell · Feb 23, 2026

Kieran O'Kane

officer: Chief Commercial Officer

BDSXSell · Feb 23, 2026

Gary Anthony Pestano

officer: Chief Development Officer

BDSXSell · Feb 23, 2026

Joseph M. Busky

officer: Chief Financial Officer

QDELBuy · Feb 13, 2026

Brian J. Blaser

President and CEO

QDELBuy · Feb 13, 2026

SCHULER JACK W

Director

BDSXBuy · Jan 27, 2026

Explore More Insider Trading Data

BDSX Insider Trading Activity

View all insider trades at Biodesix, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity